CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Grant or award Chief Medical Officer acquired 725 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 803 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 1,750 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes President and CEO gave up 2,577 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President and CEO gave up 1,999 shares (to pay taxes)
- 8-K Event Other events
- 4 Shares withheld for taxes President and CEO gave up 1,998 shares (to pay taxes)
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale Director sold 6,000 shares at $16.08 ($96,480)
- 4 Shares withheld for taxes President and CEO gave up 1,998 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
Page 19 of 74 · 1,467 filings